BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Floyd K. Costs and effectiveness--the impact of economic studies on TB control. Tuberculosis (Edinb) 2003;83:187-200. [PMID: 12758211 DOI: 10.1016/s1472-9792(02)00077-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, Datta S, Saunders MJ, Lewis JJ, Gilman RH, Evans CA. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Organ 2017;95:270-80. [PMID: 28479622 DOI: 10.2471/BLT.16.170167] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 8.2] [Reference Citation Analysis]
2 Boccia D, Pedrazzoli D, Wingfield T, Jaramillo E, Lönnroth K, Lewis J, Hargreaves J, Evans CA. Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities. BMC Infect Dis 2016;16:307. [PMID: 27329161 DOI: 10.1186/s12879-016-1529-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
3 Wingfield T, Boccia D, Tovar MA, Huff D, Montoya R, Lewis JJ, Gilman RH, Evans CA. Designing and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru. BMC Public Health 2015;15:810. [PMID: 26293238 DOI: 10.1186/s12889-015-2128-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.5] [Reference Citation Analysis]
4 Azman AS, Golub JE, Dowdy DW. How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India. BMC Med 2014;12:216. [PMID: 25358459 DOI: 10.1186/s12916-014-0216-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
5 Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, Lönnroth K, Evans CA. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med 2014;11:e1001675. [PMID: 25025331 DOI: 10.1371/journal.pmed.1001675] [Cited by in Crossref: 134] [Cited by in F6Publishing: 147] [Article Influence: 14.9] [Reference Citation Analysis]
6 Barter DM, Agboola SO, Murray MB, Bärnighausen T. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review. BMC Public Health 2012;12:980. [PMID: 23150901 DOI: 10.1186/1471-2458-12-980] [Cited by in Crossref: 88] [Cited by in F6Publishing: 107] [Article Influence: 8.0] [Reference Citation Analysis]
7 Ayé R, Wyss K, Abdualimova H, Saidaliev S. Household costs of illness during different phases of tuberculosis treatment in Central Asia: a patient survey in Tajikistan. BMC Public Health 2010;10:18. [PMID: 20078897 DOI: 10.1186/1471-2458-10-18] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kik SV, Olthof SP, de Vries JT, Menzies D, Kincler N, van Loenhout-Rooyakkers J, Burdo C, Verver S. Direct and indirect costs of tuberculosis among immigrant patients in the Netherlands. BMC Public Health 2009;9:283. [PMID: 19656370 DOI: 10.1186/1471-2458-9-283] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
9 Currie CS, Floyd K, Williams BG, Dye C. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence. BMC Public Health 2005;5:130. [PMID: 16343345 DOI: 10.1186/1471-2458-5-130] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
10 Baltussen R, Floyd K, Dye C. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. BMJ 2005;331:1364. [PMID: 16282379 DOI: 10.1136/bmj.38645.660093.68] [Cited by in Crossref: 79] [Cited by in F6Publishing: 86] [Article Influence: 4.4] [Reference Citation Analysis]
11 Fraisse P. En Inde, entre 1995 et 2002, le programme « DOTS » a permis de débuter 1,2 million de traitements anti-tuberculeux, de sauver 200 000 vies et de prévenir 2,4 millions d’infections tuberculeuses. Revue des Maladies Respiratoires 2004;21:140-143. [DOI: 10.1016/s0761-8425(04)72034-3] [Reference Citation Analysis]